TJ

Trey Jennings

Bioinformatics Student

San Francisco, California

Overview 

Trey Jennings is a Bioinformatics student based in San Francisco, California, with a Master of Science from Stanford University School of Medicine and experience in investment banking at Wells Fargo Securities. He has served as a Board Observer for multiple companies such as Avalyn Pharma and Neocis Inc., and has held roles at Norwest Venture Partners and Senti Biosciences in business development and new product planning.

Work Experience 

  • Board Observer

    2020 - 2023

  • Board Observer

    2019 - 2023

  • Senior Associate

    2019 - 2023

    Focused on venture capital investments in the healthcare sector, including biopharma, medical devices, digital health and healthcare IT, technology-enabled healthcare services, and diagnostics.

Norwest Venture Partners is a venture capital and growth equity investment firm that specializes in venture and growth equity companies.

  • Board Observer

    2020 - 2023

Monogram Health is a specialty provider of evidence-based in-home care and benefit management services for polychronic patients.

Raised $555,149,998.00 from Heritage Group, Cigna Ventures, CVS Health, Humana, Scan, Frist Cressey Ventures, Norwest Venture Partners, Pura Vida Investments, TPG and Memorial Hermann Hospital.

  • Board Observer

    2019 - 2023

TigerConnect is a healthcare collaboration platform that streamlines clinical workflows and systems.

Raised $433,900,000.00 from Vista Equity Partners.

  • Board Observer

    2019 - 2023

VisitPay equips healthcare distributors with tools and insights to manage the complexities of the patient receivables market.

Raised $25,939,672.00 from Norwest Venture Partners.

  • Board Observer

    2019 - 2021

  • Business Development & New Product Planning

    2018 - 2019

Senti Biosciences is a biotechnology company that focuses on synthetic biology and gene circuit engineering for therapeutic applications.

Raised $261,500,000.00 from California Institute for Regenerative Medicine.

  • Investment Banking Analyst

    2016 - 2018

    Life Sciences coverage

Wells Fargo & Company is a financial services firm that provides banking, insurance, investments, and mortgage services.

  • Early Stage Drug Development

    2015 - 2015

    Researched exploratory and early-stage drug targets in Neuroinflammatory and Neurodegenerative CNS disease Worked with drug development project teams to develop a strategy and plan for an asset transitioning from preclinical to clinical development Gained further experience with: Western Blot, ELISA, Immunohistochemistry, cell culture, protein purification, animal models of neurodegenerative disease and PCR

Pfizer is a biopharmaceutical company that provides affordable access to safe, effective medicines and health care services.

Raised $32,000,000,000.00 from Starboard Value.

Articles About Trey

Relevant Websites